Mentions
Extended reach
Total likes
Video views
AI synopsis
The discussions primarily acknowledge the publication as an interesting scientific study without strong opinions, using neutral language like 'new research' and 'interesting findings.' The tone indicates a basic curiosity but not a deep engagement or critical analysis, which explains the neutral scores across dimensions.
The posts do not express strong disagreement or full support, indicating a neutral stance overall.
The discussions show some curiosity about neuropeptide levels but lack detailed engagement or critique.
Comments are minimal and do not delve deeply into methodology or implications, reflecting a moderate level of engagement.
The overall discourse suggests limited perception of the study's immediate significance or transformative potential.
New Article: Plasma neuropeptide levels in patients with schizophrenia, bipolar disorder, or major depressive disorder and healthy controls: A multiplex immunoassay study https://t.co/LRpZmXQ1mq
Plasma neuropeptide levels in patients with schizophrenia, bipolar disorder, or major depressive disorder and healthy controls: A multiplex immunoassay study https://t.co/M86CmXxW9F
This study investigates plasma neuropeptide levels in patients with schizophrenia, bipolar disorder, major depressive disorder, and healthy controls using multiplex immunoassay techniques.
New Article: Plasma neuropeptide levels in patients with schizophrenia, bipolar disorder, or major depressive disorder and healthy controls: A multiplex immunoassay study https://t.co/LRpZmXQ1mq
Plasma neuropeptide levels in patients with schizophrenia, bipolar disorder, or major depressive disorder and healthy controls: A multiplex immunoassay study https://t.co/M86CmXxW9F
NN
PB